Navigation Links
ResearchDx and CompanDX Announce Strategic Partnership

IRVINE, Calif., June 17, 2011 /PRNewswire/ -- ResearchDx, LLC of Irvine, California today announced a strategic partnership with CompanDX of Nottingham UK.  ResearchDx and CompanDX have forged a unique partnership to offer a full capability to discover and deliver novel molecular diagnostic tests for clients in the healthcare setting.  CompanDX uses its unique "Distiller" platform to deliver small composite biomarker signatures from complex data of high dimensionality, which are commonplace in clinical development of therapeutics.  ResearchDx draws on its broad capability to design, produce and validate tests ready for the market and represents a new breed of service provider, the first CDO to offer turnkey solutions for companion diagnostic delivery.

"Our partnership with CompanDX completes our service offerings," said Founders of ResearchDx, Dr. Philip Cotter and Dr Mathew Moore.  "CompanDX's unique capabilities allow us to fully integrate bioinformatics into development of a diagnostic product from early in the discovery process. Our customers can trust ResearchDx to meet scientific challenges with a focus on their business priorities."

The new partnership will allow clients to initiate the parallel development of companion diagnostic tests from the very earliest stages of drug development.  CompanDX has developed a set of industry-leading tools to deliver definitive understanding of mechanism of action and biomarkers that describe patient response.  Andy Sutton, CEO of CompanDX commented, "ResearchDx occupies a space in the development of companion diagnostics that is highly complementary with our discovery platform.  Both companies strive to provide innovative solutions, cutting-edge capabilities, and outcome focused delivery. We are thrilled to dovetail into ResearchDx's downstream delivery by providing the biomarkers tailored to client's drug candidates that will form the basis of validated tests for use in the clinic."

ResearchDx is a Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx offers the services and solutions to meet complex diagnostics development needs.   ResearchDx's primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting.  Additional information is available at   ResearchDx will be exhibiting at DIA 2011 in Chicago, IL, June 19 – 22, booth #1238 and Chairing the session "Pharma-Diagnostics Relationship" at the Next Generation DX Summit in Washington D.C., August 23 – 25, 2011.

CompanDX is a molecular diagnostics company focused on biomarker discovery that uses its unique "Distiller" platform to derive small composite biomarker panels defining patient populations of significant unmet need.  Working with Pharma and biotech companies CompanDX offers the opportunity to deliver stratified clinical trials utilizing companion diagnostic tests based on biomarkers derived from the "Distiller" bioinformatics platform. Privately-held, CompanDX is based in Nottingham, UK. Investors in the company include Lachesis and Mobius Funds. Additional information is available at

Media Contact:

Philip D. Cotter, PhD, FACMG, FFSc (RCPA)
Suite 147, 13766 Alton Parkway
Irvine, CA 92618
866-225-9195 / 510-332-0477

SOURCE ResearchDx
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
(Date:11/24/2015)... Cepheid (NASDAQ: CPHD ) today announced ... conference, and invited investors to participate via webcast. ... December 1, 2015 at 11.00 a.m. Eastern Time ... December 1, 2015 at 11.00 a.m. Eastern Time ... York, NY      Tuesday, December 1, 2015 at ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... year and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual ... November 2015, where ISPE hosted the largest number of attendees in more than ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
Breaking Biology Technology:
(Date:11/19/2015)... -- Although some 350 companies are actively involved in molecular ... according to Kalorama Information. These include Roche Diagnostics, Hologic, Abbott ... of the 6.1 billion-dollar molecular testing market, according to ... Diagnostic s .    ... one company and only a handful of companies can ...
(Date:11/17/2015)... 17, 2015 Paris ... --> Paris , qui s,est ... DERMALOG, le leader de l,innovation biométrique, a inventé le ... et empreintes sur la même surface de balayage. Jusqu,ici, ... l,autre pour les empreintes digitales. Désormais, un seul scanner ...
(Date:11/12/2015)... 2015  A golden retriever that stayed healthy despite ... has provided a new lead for treating this muscle-wasting ... Institute of MIT and Harvard and the University of ... Cell, pinpoints a protective gene that ... effects. The Boston Children,s lab of Lou Kunkel ...
Breaking Biology News(10 mins):